BioCentury
ARTICLE | Distillery Therapeutics

Inflammation

December 4, 2018 1:28 PM UTC

Mouse and guinea pig studies identified an inhalable JAK-1 inhibitor that could help treat asthma without the side effects of systemic JAK suppression. The inhalable compound is a previously reported ...

BCIQ Company Profiles

Genentech Inc.

Roche

BCIQ Target Profiles

Janus kinase-1 (JAK-1)